Mucosal Melanomas of the Head and Neck : The Role of Postoperative Radiation Therapy

Abstract EN

Objectives.

Mucosal melanomas are rarer than their cutaneous counterparts and are associated with a poorer prognosis.

We report the clinical outcomes of patients with mucosal melanomas of the head and neck region generally treated with definitive surgery followed by postoperative radiation therapy (RT).

Methods.

We reviewed the records of 17 patients treated at the University of Miami in 1990–2007.

Patients generally received conventionally fractionated RT regimens to the postoperative bed.

Elective nodal RT was not routinely delivered.

Eight patients received adjuvant chemotherapy or immunotherapy.

Results.

Median followup was 35.2 months (range 5–225).

As the first site of failure: 3 patients recurred locally, 2 regionally and 2 distantly.

All 3 patients who recurred locally had not received RT.

Of the 5 locoregional recurrences, 4 were salvaged successfully with multimodality therapy with no evidence of disease at last followup.

Overall survival was 64.7% at 2 years and 51.5% at 5 years.

Conclusions.

Patients with mucosal melanoma of the head and neck are best treated with surgery to achieve negative margins, followed by postoperative RT to optimize local control.

Elective nodal irradiation may not be indicated in all cases, as regional failures were not predominant.

Distant metastases were fewer when compared to historical data, potentially due to advancements in adjuvant therapies as well as aggressive multi-modality salvage at time of failure.